Grifols, S.A.

Equities

GRF

ES0171996087

Pharmaceuticals

Market Closed - BME 11:35:12 2024-05-24 am EDT After market 02:53:55 pm
9.164 EUR +0.15% Intraday chart for Grifols, S.A. 9.219 +0.60%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Tech Stocks Lead European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading MT
European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading MT
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Friday Trading MT
GRIFOLS : In line Q1 and on track deleveraging; worth a go Alphavalue
Grifols, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Grifols swings to first-quarter profit, says guidance on track RE
Grifols' CFO Alfredo Arroyo Will Leave Company Next Year RE
GRIFOLS' CFO ALFREDO ARROYO WILL LEAVE COMPANY NEXT Y… RE
Grifols posts first-quarter profit of 21 million euros RE
GRIFOLS CEO SAYS CAN CONFIRM SHANGHAI RAAS TRANSACTION WILL CLO… RE
Transcript : Grifols, S.A., Q1 2024 Earnings Call, May 14, 2024
Spain's Grifols swings to first-quarter profit of 21 mln euros RE
Grifols shares fall after new Gotham City Research report RE
European Equities Traded in the US as American Depositary Receipts Kick Off Week Higher MT
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading MT
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Wednesday Trading MT
Sector Update: Health Care Stocks Advance in Monday Afternoon Trading MT
Grifols Shares Rise as Haier Deal Set to Close in June MT
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading MT
Grifols Expects June Completion of Haier Group Deal MT
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Set to Close Week Lower MT
European Equities Traded in the US as American Depositary Receipts Rise Modestly Higher in Thursday Trading MT
European Equities Traded in the US as American Depositary Receipts Trend Modestly Lower in Wednesday Trading MT
Grifols Issues EUR1 Billion Notes Due 2030 MT
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Monday Trading MT
Chart Grifols, S.A.
More charts
Grifols, S.A. specializes in the research, development, manufacturing and marketing of therapeutic products and medical devices for use in hospitals and medical analysis laboratories. Net sales break down by family of products and services as follows: - products derived from plasma (84.3%): products for use by the pharmaceutical and biotechnology industries; - diagnostic machines and reagents (10.2%): in vitro hemophilic diagnostic equipment, coagulation analyzers, infectious serology reagents, etc. for use primarily by blood banks and transfusion centers; - hospital products (2.4%): non-biological surgical products, radiology and nutritional products, etc. for use by hospital pharmacies; - other (3.1%): primarily intermediate biological products and subcontracted manufacturing services. Net sales are distributed geographically as follows: Spain (5.5%), European Union (13.6%), the United States and Canada (59.1%) and other (21.8%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
9.15 EUR
Average target price
16.88 EUR
Spread / Average Target
+84.47%
Consensus
  1. Stock Market
  2. Equities
  3. GRF Stock
  4. News Grifols, S.A.
  5. Grifols’ Nucleic Acid Test for Arbovirus Detection Gets CE Marking